IOL Chemicals and Pharmaceuticals Ltd successfully completes ANVISA GMP audit

IOL Chemicals and Pharmaceuticals Limited has successfully completed the Brazilian Health Regulatory Agency (ANVISA) GMP audit of all the 10 APIs manufacturing Units situated at Barnala, Punjab without any observation. The inspection was conducted from 11th March 2024 to 15th March 2024.

Shares of IOL Chemicals and Pharmaceuticals Limited was last trading in BSE at Rs. 361.50 as compared to the previous close of Rs. 355.70. The total number of shares traded during the day was 28803 in over 973 trades.

The stock hit an intraday high of Rs. 364.70 and intraday low of 359.85. The net turnover during the day was Rs. 10426118.00.

Source : Equity Bulls

Keywords

IOLChemicalsandPharmaceuticals INE485C01011 IOLCP ANVISA GMPAudit Barnala Punjab ManufacturingUnit